Evaluation of non-invasive cardiac imaging in diagnosis of chronic coronary artery disease - INAHTA Brief
This assessment originates from three different requests: from the Ministry of Health, the National Health Insurance and professional cardiology and radiology organisations. The objective is to define the place of non-invasive cardiac imaging tests in the diagnostic management of stable coronary artery disease in patients with an intermediate risk (or pretest probability). The objective being to reserve coronary angiography, an invasive test, for patients for whom it is essential (in light of a possible coronary revascularisation).
The non-invasive imaging tests involved in this report are: exercise or pharmacological stress echocardiography, coronary CT scan, pharmacological stress MRI, exercise or pharmacological stress myocardial tomography (SPECT), and positron emission tomography (PET) with 18FDG.
It should be noted that a first part addressing non-invasive cardiac imaging in non-ST-segment elevation acute coronary syndrome (ACS) at low cardiovascular risk was published by HAS in March 2015.